Grifols appoints new CEO Nacho Abia to the board

OLYMPUS

27/02/2024 08:05

MADRID, Feb 27 (Reuters) - Spanish pharmaceutical
company Grifols  GRLS.MC  said on Tuesday it had appointed Nacho
Abia as a board member, following the announcement of his hiring
as Chief Executive on Feb. 5.
     The company changed its corporate governance earlier this
month, weeks after short-seller Gotham City issued a report
questioning the company's accounting and triggering a sell-off
in its shares.
    Abia, a former top executive at Tokyo-based medical firm
Olympus  7733.T  will take over on April 1.
    Thomas Glanzmann, who is currently CEO and executive
chairman, will continue as chairman.
    The company also said Raimon Grifols and Victor Grifols,
respectively Chief Corporate Officer and Chief Operating
Officer, will voluntarily leave their jobs, though both will
remain board members.    

 (Reporting by Inti Landauro; Editing by Kirsten Donovan)
 ((Inti.Landauro@thomsonreuters.com;))